Articles
OPKO completes Latin American acquisition
The purchase allows OPKO to expand its Latin American presence, in addition to complementing its business units in Chile and Mexico, and will enable commercialization of the OPKO 4Kscore prostate cancer test in Brazil as a reference laboratory testWritten byJeffrey Bouley
| 1 min read

To continue reading this article, subscribe for FREE to
Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.
About the Author
This person does not yet have a bio.View Full Profile








